Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches

Bullous pemphigoid (BP) is one of the most common autoimmune bullous diseases and mainly affects an elderly population with multi-morbidity. Due to the frailty of many BP patients, existing treatment options are limited. The blisters associated with BP result from IgG and IgE autoantibodies binding...

Descripción completa

Detalles Bibliográficos
Autores principales: Toh, Wu Han, Lee, Hua-En, Chen, Chun-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442825/
https://www.ncbi.nlm.nih.gov/pubmed/37614956
http://dx.doi.org/10.3389/fmed.2023.1196946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442825/
https://www.ncbi.nlm.nih.gov/pubmed/37614956
http://dx.doi.org/10.3389/fmed.2023.1196946

Ejemplares similares